Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

<< Previous

Bullboard Posts

Next >>

Post by 4Justiceon Aug 17, 2021 12:03pm

65 Views

Post# 33717091

ANALYSTS

What are they waiting for ?

They supposed to follow LIMINAL and able to do some realistic recommendations.

This is old stuff. Liminal is waiting for your commitment.

BLOOM BURTON&CO
H C WAINWRIGHT
LEEDE JONES GAB
PIPER SANDLER

$3.4

Based on analysts offering 12 month price targets for LMNL in the last 3 months. The average price target is $3.4 with a high estimate of $4.5 and a low estimate of $2.3. Sign in to your SmartPortfolio to see more analyst recommendations.